WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael BenkowitzPRESIDENT AND COO2024-11-071,855$401.65
$745.07kSell
Michael BenkowitzPRESIDENT AND COO2024-11-071,895$400.30
$758.57kSell
Michael BenkowitzPRESIDENT AND COO2024-11-073,750$111.00
$416.25kBuy
Michael BenkowitzPRESIDENT AND COO2024-11-07604$403.14
$243.50kSell
Michael BenkowitzPRESIDENT AND COO2024-11-072,640$402.40
$1.06MSell
Michael BenkowitzPRESIDENT AND COO2024-11-075,702$401.55
$2.29MSell
Michael BenkowitzPRESIDENT AND COO2024-11-072,304$400.39
$922.50kSell
Michael BenkowitzPRESIDENT AND COO2024-11-0711,250$102.11
$1.15MBuy
Paul A. MahonEVP GENERAL COUNSEL2024-11-077,700$402.57
$3.10MSell
Paul A. MahonEVP GENERAL COUNSEL2024-11-077,700$163.30
$1.26MBuy

1 of 115

UTHR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.25%5,469,014$2.24BInstitution
Lilly Co Eli11.76%5,251,394$2.15BInsider
Vanguard Group Inc9.90%4,418,963$1.81BInstitution
Wellington Management Group LLP7.36%3,285,289$1.35BInstitution
Avoro Capital Advisors LLC6.40%2,858,888$1.17BInstitution
State Street Corp5.14%2,294,233$940.64MInstitution
Renaissance Technologies LLC4.87%2,174,692$891.62MInstitution
Citigroup Inc3.64%1,625,605$666.50MInstitution
Geode Capital Management LLC2.35%1,048,449$429.86MInstitution
Lsv Asset Management2.16%966,370$396.21MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.89%12.11%Net BuyingNet Buying
MRNA68.14%22.75%Net SellingNet Selling
INCY77.67%22.33%Net SellingNet Selling
SMMT9.79%89.76%Net BuyingNet Buying
RPRX53.65%16.82%Net SellingNet Buying

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 102.54% institutional shareholders, 14.13% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.76% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.15B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.